Lbp Am Sa Raises Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

LBP AM SA increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 40.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 69,934 shares of the medical device company's stock after purchasing an additional 20,021 shares during the period. LBP AM SA's holdings in Cooper Companies were worth $5,899,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. City Holding Co. bought a new position in shares of Cooper Companies in the first quarter valued at approximately $34,000. New Age Alpha Advisors LLC bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $38,000. Covestor Ltd lifted its holdings in shares of Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares in the last quarter. Atala Financial Inc bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $51,000. Finally, HM Payson & Co. lifted its holdings in shares of Cooper Companies by 147.4% in the first quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after purchasing an additional 532 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Stock Down 2.5%

Shares of COO stock traded down $1.92 during midday trading on Friday, reaching $74.78. 1,316,835 shares of the stock were exchanged, compared to its average volume of 1,741,578. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The firm has a market cap of $14.95 billion, a PE ratio of 36.28, a price-to-earnings-growth ratio of 1.83 and a beta of 0.99. The company's 50 day moving average is $75.07 and its two-hundred day moving average is $82.84. The Cooper Companies, Inc. has a 1 year low of $65.00 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The firm's quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.85 EPS. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on COO shares. Wells Fargo & Company lowered their target price on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research note on Friday, May 30th. Robert W. Baird reduced their target price on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research report on Friday, May 30th. BNP Paribas raised Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. UBS Group raised Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. Finally, Piper Sandler reissued an "overweight" rating and issued a $105.00 target price (down previously from $115.00) on shares of Cooper Companies in a research note on Friday, May 30th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, Cooper Companies currently has an average rating of "Moderate Buy" and a consensus target price of $99.70.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.